The Sargramostim for Injection, cataloged under National Stock Number 6505-01-654-2233, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Partner Therapeutics, Inc.. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-654-2233 |
| Primary Part Number | NDC71837-5843-05 |
| Item Name | Sargramostim for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Partner Therapeutics, Inc. |
| Status | ACTIVE |
| Administration | SUBCUTANEOUS AND INTRAVENOUS INFUSION |
| Primary Container Content Quantity | 250.00 MICROGRAMS |
| Usual Dose | 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Physical Form | FREEZE-DRIED POWDER |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| Active Medicament Medicinal Strength | 250.00 MICROGRAMS SARGRAMOSTIM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC71837-5843-05 PRIMARY | Partner Therapeutics, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1402758 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM162796 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-654-2233 is a Sargramostim for Injection, manufactured by Partner Therapeutics, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-654-2233 has 1 manufacturer part number on file: NDC71837-5843-05 (Partner Therapeutics, Inc.).
Key specifications for NDC71837-5843-05: Administration: SUBCUTANEOUS AND INTRAVENOUS INFUSION; Primary Container Content Quantity: 250.00 MICROGRAMS; Usual Dose: 250 MCG/M2/DAY FOR 14 DAYS AS A 2-HOUR IV INFUSION; THE DOSE CAN BE REPEEATED AFTER 7 DAYS OFF THERAPY IF ENGRAFTMENT HAS NOT OCCURRED; IF ENGRAFTMENT STILL HAS NOT OCCURRED, A THIRD COURSE OF 500 MCG/M2/DAY FOR 14 DAYS MAY BE TRIED AFTER ANOTHER 7 DAYS OFF THERAPY; Features Provided: STERILE. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.